Lululemon Faces Scrutiny, Peptides Go Clinical, Connection Economy Rises
Episode 2 min 58s

Lululemon Faces Scrutiny, Peptides Go Clinical, Connection Economy Rises

April 15, 2026: Your daily rundown of health and wellness news, in under 5 minutes.

Today's top stories:

  • Protocole launches with $6M funding to build clinical-grade peptide platform connecting users to licensed clinicians and regulated pharmacies amid FDA scrutiny
  • Posh raises $37M to scale real-world experiences as connection economy shifts from screens to in-person events, backed by Ari Emanuel and Mark Cuban
  • Texas AG investigates Lululemon over potential health risks tied to "forever chemicals" as 70%+ of US adults worry about chemical exposure in clothing

More from Fitt:

Fitt Insider breaks down the convergence of fitness, wellness, and healthcare — and what it means for business, culture, and capital.

Subscribe to our newsletter → insider.fitt.co/subscribe

Work with our recruiting firm → https://talent.fitt.co/

Follow us on Instagram → https://www.instagram.com/fittinsider/

Follow us on LinkedIn → linkedin.com/company/fittinsider

Reach out → [email protected]

Community discussion